SPONSOR
Roswell Park Cancer Institute
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Early Stage Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Non-Muscle Invasive Bladder CarcinomaRecurrent Bladder CarcinomaRecurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 1 Bladder Cancer AJCC v8Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Early Stage Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Non-Muscle Invasive Bladder Carcinoma.
The trial portfolio spans Phase 2, Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Roswell Park Cancer Institute
How many clinical trials has Roswell Park Cancer Institute sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Roswell Park Cancer Institute, of which 11 are actively recruiting participants. These trials cover conditions including Early Stage Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Roswell Park Cancer Institute research focus on?
Roswell Park Cancer Institute clinical trials span Early Stage Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Non-Muscle Invasive Bladder Carcinoma, Recurrent Bladder Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Roswell Park Cancer Institute clinical trial?
To participate in a Roswell Park Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Roswell Park Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Roswell Park Cancer Institute
NCT07718672 Phase 2
Recruiting
Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer
Early Stage Lung Non-Small Cell Carcinoma
NCT06733363 Phase 2
Recruiting
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Non-Muscle Invasive Bladder Carcinoma
NCT06206863
Recruiting
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
Hematopoietic and Lymphoid System Neoplasm
NCT05893940
Recruiting
Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
Hematopoietic and Lymphoid System Neoplasm
NCT06307548 Phase 1, Phase 2
Recruiting
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Locally Advanced Colorectal Carcinoma
NCT06074666
Recruiting
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Acute Lymphoblastic Leukemia, Pediatric
NCT06627751 Phase 2
Recruiting
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Extramedullary Disease in Multiple Myeloma
NCT06816459 EARLY_Phase 1
Recruiting
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Cigarette Smoking-Related Carcinoma
NCT04696575 Phase 2
Recruiting
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Extensive Stage Lung Small Cell Carcinoma
NCT03965234 Phase 1, Phase 2
Recruiting
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Metastatic Bone Sarcoma
NCT06323044
Recruiting
MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
Acute Lymphoblastic Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology